PublicationsDiatech Admin2018-12-12T10:54:12+01:00

Publications

Leader in the development, production and
commercialisation of pharmacogenetics tests
for cancer precision medicine.

906, 2015

Marta Schirippa et al., BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection. British Journal of Cancer

806, 2015

Hauck, F., Oliveira-Silva, M., Dreyer, J.H. et al. Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany. Virchows Arch (2015) 466: 685.

806, 2015

Lo Dico, A., Martelli, C., Valtorta, S. et al. Identification of imaging biomarkers for the assessment of tumour response to different treatments in a preclinical glioma model. Eur J Nucl Med Mol Imaging (2015) 42: 1093.

705, 2015

Corrado Iaccarino et al., Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy. Clinical Neurology and Neurosurgery

705, 2015

Riccardo Giampieri et al., Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab. Journal of Translational Medicine

105, 2015

Chiara Colato et al., Break–apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements. European Journal of Endocrinology

604, 2015

Mariani S, Di Bello C, Bonello L, Tondat F, Pacchioni D, Molinaro L, et al. (2015) Flexible Lab-Tailored Cut-Offs for Suitability of Formalin-Fixed Tumor Samples for Diagnostic Mutational Analyses. PLoS ONE 10(4): e0121815.

604, 2015

Daniela Massi et al., Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma. Modern Pathology

104, 2015

Giovanna De Maglio et al., MGMT promoter methylation status in brain metastases from colorectal cancer and corresponding primary tumors. Future Oncology

104, 2015

Giulia Cini et al., Concomitant mutation and epimutation of the MLH1 gene in a Lynch syndrome family. Carcinogenesis

903, 2015

Elisa Chiadiniet al., EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab. Oncology Letters

102, 2015

Luisa Foltran et al., Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer. Future Oncology

Previous 272829 Next